-
Be the first to like this
Slideshare uses cookies to improve functionality and performance, and to provide you with relevant advertising. If you continue browsing the site, you agree to the use of cookies on this website. See our User Agreement and Privacy Policy.
Slideshare uses cookies to improve functionality and performance, and to provide you with relevant advertising. If you continue browsing the site, you agree to the use of cookies on this website. See our Privacy Policy and User Agreement for details.
Scribd will begin operating the SlideShare business on September 24, 2020 As of this date, Scribd will manage your SlideShare account and any content you may have on SlideShare, and Scribd's General Terms of Use and Privacy Policy will apply. If you wish to opt out, please close your SlideShare account. Learn more.
Published on
Advertisements for branded, patented pharmaceutical drugs often have effects that go beyond providing information to patients. The ads are also about “business-stealing,” i.e. convincing consumers to buy one firm’s drug over that of a rival. In a positive spillover, the ads also encourage patients to visit their doctors to check on different medical conditions, but potentially drive them to cheaper, generic equivalents of the branded drugs that are advertised.
Those are the findings of a recent research study conducted by Wharton’s Michael Sinkinson, a professor of business economics and public policy and Amanda Starc, a professor of health care management. Their research paper, titled “Ask Your Doctor? Direct-to-Consumer Advertising of Pharmaceuticals,” is unique in separating the business-stealing effect from the informational effect of the ads.
Sinkinson recently discussed the research with Knowledge@Wharton. More: http://knlg.net/1g7ZDzU
Be the first to like this
Be the first to comment